Transcarent Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
454
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Investors
-
22
Transcarent General Information
Description
Developer of a consumer-directed health and care platform that improves outcomes and supports cost-effective decisions. The company leverages a combination of software, a technology stack, and data science to empower consumers with information by connecting them with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency in addressing a broad range of challenges faced in the modern healthcare system.
Contact Information
Website
www.transcarent.comCorporate Office
- 4700 South Syracuse Street
- Suite 900
- Denver, CO 80237
- United States
Corporate Office
- 4700 South Syracuse Street
- Suite 900
- Denver, CO 80237
- United States
Transcarent Timeline
Transcarent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | Upcoming | Generating Revenue | ||||
| 5. Later Stage VC (Series D1) | 07-Apr-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 06-Mar-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 11-Jan-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 10-Jun-2021 | $58M | $98M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 18-Jun-2020 | $40M | $40M | Completed | Startup |
Transcarent Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-2 | 3,440,641 | $0.000010 | $0.98 | $0.98 | 1x | $0.98 | 2.63% | |
| Seed | 6,000,000 | $0.000010 | $0.5 | $0.5 | 1x | $0.5 | 4.58% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Transcarent Comparisons
Industry
Financing
Details
Transcarent Competitors (26)
One of Transcarent’s 26 competitors is Eden Health, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eden Health | Formerly VC-backed | New York, NY | ||||
| TriNetX | Private Equity-Backed | Cambridge, MA | ||||
| Pager Health | Venture Capital-Backed | New York, NY | ||||
| Sharecare | Private Equity-Backed | Atlanta, GA | ||||
| DocASAP | Venture Capital-Backed | Herndon, VA |
Transcarent Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Transcarent Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Transcarent Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 62 Ventures | Venture Capital | Minority | ||
| Bridgespan VC | Venture Capital | Minority | ||
| Geodesic Capital | Growth/Expansion | Minority | ||
| Memorial Hermann Foundation | Corporation | Minority | ||
| 50 South Capital Advisors | Fund of Funds | Minority |
Transcarent Acquisitions (3)
Transcarent’s most recent deal was a Merger/Acquisition with Accolade (Managed Care) for . The deal was made on 01-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Accolade (Managed Care) | 01-Apr-2025 | Merger/Acquisition | Managed Care | ||
| 98point6 | 04-Apr-2023 | Merger/Acquisition | Clinics/Outpatient Services | ||
| BridgeHealth | 22-Oct-2020 | Merger/Acquisition | Managed Care |
Transcarent Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 98point6 | Seattle, WA | 2015 | |
| Accolade (Managed Care) | Seattle, WA | 2007 |
Transcarent FAQs
-
When was Transcarent founded?
Transcarent was founded in 2020.
-
Where is Transcarent headquartered?
Transcarent is headquartered in Denver, CO.
-
What is the size of Transcarent?
Transcarent has 454 total employees.
-
What industry is Transcarent in?
Transcarent’s primary industry is Other Healthcare Technology Systems.
-
Is Transcarent a private or public company?
Transcarent is a Private company.
-
What is Transcarent’s current revenue?
The current revenue for Transcarent is .
-
How much funding has Transcarent raised over time?
Transcarent has raised $905M.
-
Who are Transcarent’s investors?
62 Ventures, Bridgespan VC, Geodesic Capital, Memorial Hermann Foundation, and 50 South Capital Advisors are 5 of 22 investors who have invested in Transcarent.
-
Who are Transcarent’s competitors?
Eden Health, TriNetX, Pager Health, Sharecare, and DocASAP are some of the 26 competitors of Transcarent.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
